We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

17 hedge funds and large institutions have $2.94M invested in Bio-Path Holdings Inc in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

11% less funds holding

Funds holding: 19 → 17 (-2)

11% less capital invested

Capital invested by funds: $3.31M → $2.94M (-$365K)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$584K
2
Northern Trust
Northern Trust
Illinois
+$109K
3
State Street
State Street
Massachusetts
+$74.8K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$64.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$54K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$518K
2
SM
Sabby Management
Florida
-$505K
3
Morgan Stanley
Morgan Stanley
New York
-$238K
4
Bank of America
Bank of America
North Carolina
-$14.4K
5
HI
Human Investing
Oregon
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.46M +$584K +4,736 +76%
BlackRock
2
BlackRock
New York
$454K +$50.8K +412 +14%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$435K +$54K +438 +15%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$188K +$64.2K +521 +59%
Citadel Advisors
5
Citadel Advisors
Florida
$169K +$29.3K +238 +23%
Northern Trust
6
Northern Trust
Illinois
$119K +$109K +887 New
State Street
7
State Street
Massachusetts
$81K +$74.8K +607 New
UBS Group
8
UBS Group
Switzerland
$27K +$24.9K +202 +6,733%
Morgan Stanley
9
Morgan Stanley
New York
$9K -$238K -1,933 -97%
IF
10
Ironwood Financial
Arizona
$1K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$1K +$1.23K +10 New
Renaissance Technologies
12
Renaissance Technologies
New York
– -$518K -3,690 Closed
SM
13
Sabby Management
Florida
– -$505K -3,596 Closed
Bank of America
14
Bank of America
North Carolina
– -$14.4K -117 -97%
HI
15
Human Investing
Oregon
– -$14K -100 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
– -$10.2K -83 -99%
CAPTRUST Financial Advisors
17
CAPTRUST Financial Advisors
North Carolina
– -$2K -13 Closed
CA
18
Crewe Advisors
Utah
– +$493 +4 New

BPTH Hedge Fund Activity: Q2 2021 in Review

17 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2021, worth a combined $2.94M — down 11% from $3.31M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BPTH and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $584K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $518K sold.

  • 17 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2021, down from 19 in Q1 2021.
  • Funds reported $2.94M of Bio-Path Holdings Inc stock for Q2 2021, down 11% quarter-over-quarter.
  • 4 funds opened new Bio-Path Holdings Inc positions in Q2 2021 and 6 closed out, a net change of -2 holders.
  • The largest Bio-Path Holdings Inc buyer in Q2 2021 was Vanguard Group, an estimated $584K added.
  • The largest Bio-Path Holdings Inc seller in Q2 2021 was Renaissance Technologies, an estimated $518K sold.

Based on aggregated 13F filings for Q2 2021.